Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The current status of cell-free human papillomavirus DNA as a biomarker in cervical cancer and other HPV-associated tumors: a review
While no adverse cardiac events were attributed to heart rate increases in the trials, long-term cardiovascular outcomes data is needed
There was no difference in the uptake of the two types of nanocarriers between the healthy control and the PD organoids (Fig
2017;21:S620
US$ 20.38
US$ 23.66
US$ 23.23
US$ 24.50
US$ 23.10
US$ 23.23
US$ 28.77
US$ 25.18
.png)
US$ 29.78
US$ 28.14
